Stay updated on Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    - Revision label updated from v3.2.0 to v3.3.2 on the page.
    Difference
    0.0%
    Check dated 2025-11-24T18:07:17.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The notice about lapse in government funding has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T17:52:42.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The screenshots show only minor formatting and layout adjustments to the study record; no substantive data or core study elements appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T12:35:05.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Major update to core page content: adds a government funding notice and current operating status details, plus a version bump to v3.2.0; removes the previous v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-05T17:20:29.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.0%
    Check dated 2025-09-28T10:11:17.000Z thumbnail image
  9. Check
    96 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, and the Back to Top element was removed.
    Difference
    0.1%
    Check dated 2025-09-14T00:21:55.000Z thumbnail image

Stay in the know with updates to Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial page.